Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528456) titled 'Butylphthalide for Brain Edema After Endovascular Treatment' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Nanfang Hospital, Southern Medical University
Condition:
Acute Ischemic Stroke
Intervention:
Drug: Butylphthalide
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: April 1, 2026
Target Sample Size: 100
Countries of Recruitment:
China
To know more, visit https://clinicaltrial...